Oct. 13, 2004 -- The U.S. Food and Drug Administration (FDA) approved in July revisions to safety labeling to advise healthcare professionals of the following changes: tenofovir disoproxil fumarate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback